CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FiercePharma
Original article

{"a":[{"_":"Pursuing patient options, Novo kicks off trial testing smaller doses of Wegovy pill","$":{"href":"/pharma/novo-nordisk-kicks-trial-testing-smaller-doses-wegovy-pill","hreflang":"en"}}]}

Phase 3WegovyNeutral
AI Analysis

Summary

Novo Nordisk has initiated the Phase 3 OASIS 5 trial to evaluate smaller doses of its Wegovy oral pill, eight months after its market introduction.

Clinical Trial Data

Phase

Phase 3

Importance:5/10
Sentiment:
0.00
GLP-1oral formulationdose optimizationOASIS 5
Related Companies

Read the original article

Published by FiercePharma on August 19, 2026 3:04 PM

Read Original